Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Imming (Beijing) Cell Biotechnology (Yiming cells)

Request full access

Developing biological drugs

ChinaFounded 2015Biotech & Life Sciences

At a glance

Status
Operational
Employees
3
Open positions
None listed
Dealroom signal
16.1/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Client focus
B2B

Funding history

5 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES COther financing Apr 2023 $21M $138M FOF Capital · Jinan Industrial Development Group · Guotai Junan Securities ↗
SERIES COther financing Sep 2022 $28M $110M IDG Capital · Goldstone Investment · Huagai Capital · China Industrial International Trust —
Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Growth signals

Imming (Beijing) Cell Biotechnology (Yiming cells) team growth

Imming (Beijing) Cell Biotechnology (Yiming cells)'s team declined 40% over the past year.

1-year team growth-40%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Imming (Beijing) Cell Biotechnology (Yiming cells) in its local ecosystem

Live from Dealroom

The Imming (Beijing) Cell Biotechnology (Yiming cells) office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

18 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

  • Cowin Capital
  • Chiron Ventures

Series A7 investors entered at this stage

  • Huagai Capital
  • Ming Bioventures
  • Junsheng Investment
  • Fangfu Venture Capital
  • Zhongguancun Development Qihang Industrial Investment Fund
  • IDG Capital
  • Yida Capital

Series B and later9 investors entered at this stage

  • Goldstone Investment
  • China Industrial International Trust
  • CLSA Capital Partners
  • BGI Co-Win
  • Wenzhou Investment
  • Yuanchuang Duoying Capital
  • Jinan Industrial Development Group
  • Guotai Junan Securities
  • FOF Capital
Employees 3 total headcount
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇨🇳 China100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Imming (Beijing) Cell Biotechnology (Yiming cells) on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Imming (Beijing) Cell Biotechnology (Yiming cells)’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.